Tarriff Scott bought EGRX
February 27, 2024 · Form 4 insider transaction
Tarriff Scott bought 12,950 shares of Eagle Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,950
Price
N/A
Total value
N/A
InsiderTarriff Scott
Role10% owner
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after465,894
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of Common Stock received upon vesting of performance stock units ("PSUs") that were granted on February 2, 2021.; Reflects the transfer of 88,181 shares of Common Stock pursuant to a Rule 16a-12 transaction.